: FDA broadens U.S. safety inquiry into AstraZeneca COVID-19 vaccine, report says

Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer’s “unexplained illness.”

Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer’s “unexplained illness.”